Ibaraki, Japan

Shohei Horie


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shohei Horie: Innovator in Nucleic Acid Synthesis

Introduction

Shohei Horie is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of nucleic acid synthesis, holding a total of 4 patents. His work focuses on improving methods for synthesizing nucleic acids, which are essential for various applications in biotechnology and medicine.

Latest Patents

Horie's latest patents include innovative technologies that enhance the efficiency of nucleic acid synthesis. One of his notable inventions is a linker and support for solid phase synthesis of nucleic acid. This invention provides a linker consisting of specific compounds and a support structure that facilitates the synthesis process. Another significant patent is a method of cutting out RNA oligonucleotides, which minimizes byproduct production and increases the yield of the desired RNA oligonucleotide. This method involves using a universal support in contact with an aqueous solution containing alkylamine and a monovalent inorganic salt.

Career Highlights

Throughout his career, Shohei Horie has worked with prominent organizations, including Nitto Denko Corporation and Aoyama Gakuin Educational Foundation. His experience in these institutions has allowed him to develop and refine his innovative approaches to nucleic acid synthesis.

Collaborations

Horie has collaborated with talented individuals in his field, including Eri Maeta and Kenjiro Mori. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Shohei Horie is a distinguished inventor whose work in nucleic acid synthesis has led to several important patents. His innovative methods and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…